Annual ROE
-139.14%
+174.84%+55.69%
December 31, 2023
Summary
- As of February 7, 2025, TTNP annual return on equity is -139.14%, with the most recent change of +174.84% (+55.69%) on December 31, 2023.
- During the last 3 years, TTNP annual ROE has risen by +595.68% (+81.06%).
- TTNP annual ROE is now -168.98% below its all-time high of 201.72%, reached on December 31, 1995.
Performance
TTNP ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-117.99%
-30.11%-34.26%
September 30, 2024
Summary
- As of February 7, 2025, TTNP quarterly return on equity is -117.99%, with the most recent change of -30.11% (-34.26%) on September 30, 2024.
- Over the past year, TTNP quarterly ROE has increased by +47.89% (+28.87%).
- TTNP quarterly ROE is now -117.86% below its all-time high of 660.61%, reached on December 31, 2013.
Performance
TTNP Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
TTNP ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +55.7% | +28.9% |
| 3 y3 years | +81.1% | -6.8% |
| 5 y5 years | +40.7% | +70.0% |
TTNP ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +55.7% | -34.3% | +74.3% |
| 5 y | 5-year | at high | +81.1% | -34.3% | +94.2% |
| alltime | all time | -169.0% | +81.1% | -117.9% | +97.1% |
Titan Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -117.99%(+34.3%) |
| Jun 2024 | - | -87.88%(-12.1%) |
| Mar 2024 | - | -99.94%(-39.8%) |
| Dec 2023 | -139.14%(-55.7%) | -165.88%(-45.2%) |
| Sep 2023 | - | -302.58%(-34.0%) |
| Jun 2023 | - | -458.36%(+78.1%) |
| Mar 2023 | - | -257.33%(+19.0%) |
| Dec 2022 | -313.98%(+55.1%) | -216.23%(+26.3%) |
| Sep 2022 | - | -171.19%(+26.5%) |
| Jun 2022 | - | -135.37%(+22.5%) |
| Mar 2022 | - | -110.53%(-12.1%) |
| Dec 2021 | -202.45%(-72.4%) | -125.76%(-22.1%) |
| Sep 2021 | - | -161.50%(-40.0%) |
| Jun 2021 | - | -269.13%(-31.6%) |
| Mar 2021 | - | -393.27%(-53.0%) |
| Dec 2020 | -734.82%(+84.5%) | -836.48%(-58.7%) |
| Sep 2020 | - | -2026.53%(+20.3%) |
| Jun 2020 | - | -1684.10%(+25.6%) |
| Mar 2020 | - | -1341.27%(+31.8%) |
| Dec 2019 | -398.31%(+69.7%) | -1017.43%(+54.2%) |
| Sep 2019 | - | -659.63%(+16.6%) |
| Jun 2019 | - | -565.67%(+36.7%) |
| Mar 2019 | - | -413.70%(+1.0%) |
| Dec 2018 | -234.73%(+15.2%) | -409.47%(-26.6%) |
| Sep 2018 | - | -557.99%(+1.2%) |
| Jun 2018 | - | -551.15%(+75.9%) |
| Mar 2018 | - | -313.31%(+58.7%) |
| Dec 2017 | -203.69%(-500.3%) | -197.44%(+54.1%) |
| Sep 2017 | - | -128.11%(+44.4%) |
| Jun 2017 | - | -88.70%(-377.6%) |
| Mar 2017 | - | 31.95%(-27.1%) |
| Dec 2016 | 50.89%(-135.2%) | 43.81%(-7.9%) |
| Sep 2016 | - | 47.57%(-34.7%) |
| Jun 2016 | - | 72.85%(-148.8%) |
| Mar 2016 | - | -149.27%(-18.8%) |
| Dec 2015 | -144.59%(+332.4%) | -183.73%(+8.6%) |
| Sep 2015 | - | -169.16%(+9.8%) |
| Jun 2015 | - | -154.10%(+39.1%) |
| Mar 2015 | - | -110.82%(+143.2%) |
| Dec 2014 | -33.44%(-119.8%) | -45.57%(-20.0%) |
| Sep 2014 | - | -56.95%(-52.5%) |
| Jun 2014 | - | -119.95%(-227.9%) |
| Mar 2014 | - | 93.78%(-85.8%) |
| Dec 2013 | 168.59%(+156.9%) | 660.61%(-494.1%) |
| Sep 2013 | - | -167.61%(+673.1%) |
| Jun 2013 | - | -21.68%(-203.0%) |
| Mar 2013 | - | 21.05%(-66.4%) |
| Dec 2012 | 65.63%(-13.3%) | 62.63%(-17.4%) |
| Sep 2012 | - | 75.82%(+50.9%) |
| Jun 2012 | - | 50.24%(-38.0%) |
| Mar 2012 | - | 80.99%(-13.4%) |
| Dec 2011 | 75.72%(-32.9%) | 93.50%(-28.2%) |
| Sep 2011 | - | 130.19%(-25.9%) |
| Jun 2011 | - | 175.64%(-7.5%) |
| Mar 2011 | - | 189.87%(+0.4%) |
| Dec 2010 | 112.90% | 189.18%(-138.4%) |
| Sep 2010 | - | -492.98%(+290.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2010 | - | -126.28%(+118.5%) |
| Mar 2010 | - | -57.80%(+39.6%) |
| Dec 2009 | -44.62%(-51.7%) | -41.40%(-63.5%) |
| Jun 2009 | - | -113.31%(-19.4%) |
| Mar 2009 | - | -140.52%(-8.8%) |
| Sep 2008 | - | -154.12%(+14.9%) |
| Jun 2008 | - | -134.10%(+12.9%) |
| Mar 2008 | - | -118.76%(-0.9%) |
| Dec 2007 | -92.31%(-17.2%) | -119.79%(+0.5%) |
| Sep 2007 | - | -119.14%(+11.5%) |
| Jun 2007 | - | -106.82%(+10.3%) |
| Mar 2007 | - | -96.87%(+2.8%) |
| Dec 2006 | -111.42%(+27.9%) | -94.24%(+1.1%) |
| Sep 2006 | - | -93.26%(-2.5%) |
| Jun 2006 | - | -95.63%(-1.9%) |
| Mar 2006 | - | -97.53%(+4.2%) |
| Dec 2005 | -87.14%(+35.1%) | -93.58%(+4.0%) |
| Sep 2005 | - | -89.98%(+22.2%) |
| Jun 2005 | - | -73.64%(+18.3%) |
| Mar 2005 | - | -62.26%(+7.8%) |
| Dec 2004 | -64.51%(+27.0%) | -57.75%(-2.4%) |
| Sep 2004 | - | -59.15%(+7.2%) |
| Jun 2004 | - | -55.20%(+2.5%) |
| Mar 2004 | - | -53.83%(+6.0%) |
| Dec 2003 | -50.81%(+56.3%) | -50.78%(+18.2%) |
| Sep 2003 | - | -42.95%(+6.6%) |
| Jun 2003 | - | -40.30%(+8.7%) |
| Mar 2003 | - | -37.06%(+15.1%) |
| Dec 2002 | -32.51%(+102.3%) | -32.21%(+19.2%) |
| Sep 2002 | - | -27.03%(+18.1%) |
| Jun 2002 | - | -22.89%(+35.4%) |
| Mar 2002 | - | -16.90%(+6.5%) |
| Dec 2001 | -16.07%(-30.9%) | -15.87%(+10.3%) |
| Sep 2001 | - | -14.39%(-24.5%) |
| Jun 2001 | - | -19.06%(-8.4%) |
| Mar 2001 | - | -20.81%(-10.3%) |
| Dec 2000 | -23.27%(-42.2%) | -23.21%(-22.0%) |
| Sep 2000 | - | -29.75%(+20.5%) |
| Jun 2000 | - | -24.69%(-33.6%) |
| Mar 2000 | - | -37.16%(-40.9%) |
| Dec 1999 | -40.29%(-44.9%) | -62.85%(-37.3%) |
| Sep 1999 | - | -100.17%(+10.1%) |
| Jun 1999 | - | -90.98%(+21.3%) |
| Mar 1999 | - | -75.03%(+10.3%) |
| Dec 1998 | -73.10%(-1988.9%) | -68.04%(-252.6%) |
| Sep 1998 | - | 44.58%(+2.2%) |
| Jun 1998 | - | 43.63%(-69.2%) |
| Mar 1998 | - | 141.44%(+1516.5%) |
| Dec 1997 | 3.87%(-101.2%) | 8.75%(-103.4%) |
| Sep 1997 | - | -260.87%(+23.5%) |
| Jun 1997 | - | -211.23%(-23.3%) |
| Mar 1997 | - | -275.49%(+58.5%) |
| Dec 1996 | -322.50%(-259.9%) | -173.85%(-10.5%) |
| Sep 1996 | - | -194.29%(-55.7%) |
| Jun 1996 | - | -439.02%(-89.2%) |
| Mar 1996 | - | -4066.67%(-2116.0%) |
| Dec 1995 | 201.72% | 201.72% |
FAQ
- What is Titan Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals annual ROE year-on-year change?
- What is Titan Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals quarterly ROE year-on-year change?
What is Titan Pharmaceuticals annual return on equity?
The current annual ROE of TTNP is -139.14%
What is the all time high annual ROE for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high annual return on equity is 201.72%
What is Titan Pharmaceuticals annual ROE year-on-year change?
Over the past year, TTNP annual return on equity has changed by +174.84% (+55.69%)
What is Titan Pharmaceuticals quarterly return on equity?
The current quarterly ROE of TTNP is -117.99%
What is the all time high quarterly ROE for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high quarterly return on equity is 660.61%
What is Titan Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, TTNP quarterly return on equity has changed by +47.89% (+28.87%)